Braunstein David, Hardy Amélie, Boucherie Quentin, Frauger Elisabeth, Blin Olivier, Gentile Gaétan, Micallef Joëlle
Service de Pharmacologie clinique et pharmacovigilance, Hôpital de la Timone, Assistance Publique - Hôpitaux de Marseille (AP-HM), Pharmacologie Intégrée & Interface Clinique et Industrielle, Aix Marseille Université, Institut de Neurosciences de la Timone UMR 7289 CNRS, 264 rue Saint-Pierre, Marseille, 13385, France.
Département universitaire de Médecine générale, Faculté de Médecine de la Timone, Aix-Marseille Université, 27 boulevard Jean Moulin, Marseille, 13005, France.
Fundam Clin Pharmacol. 2017 Apr;31(2):226-236. doi: 10.1111/fcp.12252. Epub 2017 Jan 10.
According to the World Health Organization, depression will become the second most important cause of disability worldwide by 2020. Our objective was to identify patterns of adherence to antidepressant treatments in older patients using several indicators of adherence and to characterize these patterns in terms of medication exposure. We conducted a retrospective cohort study using the French National Health Insurance reimbursement database. Incident antidepressant users aged more than 65 were included from July 1, 2010, to June 30, 2011, and followed up for 18 months. Antidepressant and other psychotropic drugs (opioids, benzodiazepines, antipsychotics, anti-epileptics) were recorded. Adherence to antidepressant treatment was assessed by several measures including proportion of days covered, discontinuation periods, persistence of treatment, and doses dispensed. Patients were classified according to their adherence patterns using a mixed clustering method. We identified five groups according to antidepressant adherence. One group (n = 7505, 26.9%) was fully adherent with regard to guidelines on antidepressant use. Two patterns of nonadherent users were identified: irregular but persistent users (n = 5131, 18.4%) and regular but nonpersistent users (n = 9037, 32.4%). Serotonin reuptake inhibitors were the most frequently dispensed antidepressant class (70.6%), followed by other antidepressants (43.3%, mainly serotonin-norepinephrine reuptake inhibitors and tianeptine) and tricyclic antidepressants (TCAs) (13.4%). Nonadherent users more frequently had a dispensing of TCA, opioid, and anti-epileptic medication than adherent users. Health policies to improve adherence to antidepressant treatment may require better training of physicians and pharmacists, insisting on the important role of the continuation period of antidepressant treatment.
根据世界卫生组织的数据,到2020年抑郁症将成为全球第二大致残原因。我们的目标是使用多种依从性指标来确定老年患者抗抑郁治疗的依从模式,并根据药物暴露情况对这些模式进行特征描述。我们利用法国国家医疗保险报销数据库进行了一项回顾性队列研究。纳入了2010年7月1日至2011年6月30日期间年龄超过65岁的首次使用抗抑郁药的患者,并随访18个月。记录了抗抑郁药和其他精神药物(阿片类药物、苯二氮䓬类药物、抗精神病药物、抗癫痫药物)。通过包括覆盖天数比例、停药期、治疗持续性和配药剂量等多种措施评估抗抑郁治疗的依从性。使用混合聚类方法根据患者的依从模式进行分类。根据抗抑郁药依从性我们确定了五组。一组(n = 7505,26.9%)在抗抑郁药使用指南方面完全依从。确定了两种不依从使用者模式:不规律但持续使用者(n = 5131,18.4%)和规律但不持续使用者(n = 9037,32.4%)。5-羟色胺再摄取抑制剂是最常配药的抗抑郁药类别(70.6%),其次是其他抗抑郁药(43.3%,主要是5-羟色胺-去甲肾上腺素再摄取抑制剂和噻奈普汀)和三环类抗抑郁药(TCAs)(13.4%)。与依从使用者相比,不依从使用者更频繁地配用三环类抗抑郁药、阿片类药物和抗癫痫药物。改善抗抑郁治疗依从性的卫生政策可能需要对医生和药剂师进行更好的培训,强调抗抑郁治疗持续期的重要作用。